share_log

Vascular Biogenics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

SEC announcement ·  Oct 11, 2017 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more